Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FAJZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,073
Award facts
- Contract value 100% obligated
- $13,073.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $13,073.19 by the Defense Logistics Agency (DLA) on December 4, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical supplier to the Defense Health Agency and other federal military healthcare systems. Performance is scheduled for completion by December 5, 2025.
Repatha (evolocumab) is a PCSK9 inhibitor indicated for the treatment of hypercholesterolemia in patients with cardiovascular disease, representing a specialty pharmaceutical product within the broader range of medical commodities supplied through AmerisourceBergen's federal contracts. This delivery order reflects the company's ongoing role as a prime vendor supporting the DLA's Medical Supply Chain with brand-name pharmaceuticals and specialized injectable therapies across multiple therapeutic domains. The DLA's procurement strategy for pharmaceutical support continues to utilize multiple prime vendor contracts to ensure robust supply chain capabilities for military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FAJZT?
SPE2DR26FAJZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FAJZT worth?
The government has obligated $13,073 on SPE2DR26FAJZT.
Is contract SPE2DR26FAJZT an order under another contract?
Yes. SPE2DR26FAJZT is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAJZT competed?
The extent of competition for SPE2DR26FAJZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award